Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition
Clinical trial NCT01746719 · COMPLETED
Trial details
- NCT number
- NCT01746719
- Sponsor
- IPCA Laboratories Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2012-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.